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Abstract 
OBJECTIVES:  
We aimed to analyze the differentially-expressed miRNAs in colon cancer cells in order to identify novel potential 
biomarkers involved in cancer cell resistance. 
DESIGN AND METHODS:  
We investigated the miRNA expression profile of GEO human colon carcinoma cells, sensitive to the EGFR inhibitor 
Cetuximab (CTX) and their CTX-resistant counterpart (GEO CR) by using a miRNA chip. 
RESULTS:  
We found 27 upregulated and 10 downregulated miRNAs in GEO CR compared with GEO cells with a fold change ≥ 2. 
Among the upregulated miRNAs, we focused on miR-199a-5p and miR-375. We report that their enforced expression 
promotes CTX resistance, whereas their silencing sensitizes to the same drug. The ability of miR-199a-5p and miR-375 
to target PHLPP1 (PH domain and leucine-rich repeat protein phosphatase 1), a tumor suppressor that negatively 
regulates the AKT pathway, accounts, at least in part, for their drug-resistance activity. Indeed, restoration of PHLPP1 
increases sensitivity of the GEO cells to CTX and reverts the resistance-promoting effect of miR-199a-5p and miR-375. 
CONCLUSION:  
This study proposes miR-199a-5p and miR-375 as contributors to CTX resistance in colon cancer and suggests a novel 
approach based on miRNAs as tools for the therapy of this tumor. 
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